Health knowledge made personal
Join this community!
› Share page:
Search posts:

The U.S. Food and Drug Administr ...

Posted Nov 10 2008 4:21pm

The U.S. Food and Drug Administration today approved the first generic versions of Fosamax (alendronate sodium tablets), used to treat osteoporosis, a condition that causes thinning and weakening of a person's bones. image

Teva Pharmaceuticals USA, North W ales, Pa., was approved to manufacture alendronate sodium tablets in three once-daily dosing strengths (5 milligrams, 10 milligrams, and 40 milligrams) and two once-weekly dosing strengths (35 milligrams and 70 milligrams). Barr Laboratories, Inc., Montvale, N.J., was approved to manufacture a 70 milligrams once-weekly dose of the drug.

U.S. FDA approval of generic Fosamax

Post a comment
Write a comment: